[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BiotechAnalysst Phoenix Biotech XXX Phoenix Biotech XXX posts on X about $sgmo, $4503t, $xbi, pfe the most. They currently have XXXXX followers and 1075 posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::967435696188293125/interactions)  - X Week XXXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX -XX% - X Year XXXXXXXXX +51% ### Mentions: XX [#](/creator/twitter::967435696188293125/posts_active)  - X Months XXX -XX% - X Year XXX +59% ### Followers: XXXXX [#](/creator/twitter::967435696188293125/followers)  - X Week XXXXX +0.23% - X Month XXXXX +0.83% - X Months XXXXX +7.50% - X Year XXXXX +28% ### CreatorRank: XXXXXXX [#](/creator/twitter::967435696188293125/influencer_rank)  ### Social Influence [#](/creator/twitter::967435696188293125/influence) --- **Social category influence** [stocks](/list/stocks) **Social topic influence** [$sgmo](/topic/$sgmo) #1, [$4503t](/topic/$4503t) #1, [$xbi](/topic/$xbi), [pfe](/topic/pfe), [$pfe](/topic/$pfe), [aav](/topic/aav), [abbv](/topic/abbv), [$cogt](/topic/$cogt), [$repl](/topic/$repl), [$akro](/topic/$akro) **Top assets mentioned** [Bitcoin Incognito (XBI)](/topic/$xbi) [Pfizer, Inc. (PFE)](/topic/$pfe) [Akropolis (AKRO)](/topic/$akro) [Biogen Inc (BIIB)](/topic/$biib) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [AbbVie Inc (ABBV)](/topic/$abbv) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [Insmed, Inc. (INSM)](/topic/$insm) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [ADMA Biologics, Inc. (ADMA)](/topic/$adma) [ExlService Holdings, Inc. (EXLS)](/topic/$exls) [SpringWorks Therapeutics, Inc. Common Stock (SWTX)](/topic/$swtx) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Krystal Biotech, Inc. Common Stock (KRYS)](/topic/$krys) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Edgewise Therapeutics, Inc. Common Stock (EWTX)](/topic/$ewtx) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Immunogen Inc (IMGN)](/topic/$imgn) ### Top Social Posts [#](/creator/twitter::967435696188293125/posts) --- Top posts by engagements in the last XX hours "more hiring @ $SGMO X more jobs posted tonight"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1946221287711416324) 2025-07-18 14:51:28 UTC 4000 followers, 3812 engagements "$SGMO and Astellas: rAAV Gene Therapies for RARE NEURO Diseases re "Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases" #STAC_BBB"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1943340544320504047) 2025-07-10 16:04:25 UTC 4000 followers, 4276 engagements "#Astellas say #gene #editing might be next . $SGMO Astellas is doubling down on gene therapy Building an end-to-end AAV platform from research to commercial Strategic partnerships driving CNS and rare disease programs"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1945847971930587337) 2025-07-17 14:08:03 UTC 4000 followers, 3197 engagements "Bernsten $XBI M&A - Who might buy whom largest demand: $MRK $PFE $BMY $ABBV and $BIIB targets: $TGTX $INSM $AXSM $ADMA $EXLS $ASND $SWTX $BBIO $KRYS $BPMC $RVMD $SMMT $SRRK $QURE $RYTM $AKRO $MRUS $EWTX $REPL $COGT"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1899379866010563054) 2025-03-11 08:40:23 UTC 4000 followers, 21.7K engagements "$XBI Biggest Biotech Outflows in Years ($1.546B of net outflows last week) but $CRSP insider buys for 50milli (or half a $SGMO marketcap)"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1946202239569215499) 2025-07-18 13:35:47 UTC 4000 followers, 2335 engagements "#Astellas says "We see #more platform #development together with (them) Sangamo $SGMO to actually create the next generation of gene therapy .#neuromuscular disease strategy"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1943343969917702384) 2025-07-10 16:18:02 UTC 4000 followers, 5883 engagements "$sgmo Said has dmd cure ready in fridge Roche should dump $srpt and go all in $sgmo. As for sangamo it was always patients first"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1946647237041291368) 2025-07-19 19:04:02 UTC 4000 followers, 2429 engagements "#Astallas says: "We look at predominantly #Gene #replacement ." re $SGMO #MINT"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1945849065096306697) 2025-07-17 14:12:23 UTC 4000 followers, 3111 engagements "$PROK minus VS $SGMO plus eGFR Kidney slope"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1942901183674286122) 2025-07-09 10:58:34 UTC 4000 followers, 6621 engagements "@GeneInvesting @ShortsellerST yes thats X of many new ones AAV9 had often problems ie $PFE DMD death too $SGMO uses rAAV2/6 for fabry w/o problems the next gen delivery capsids from $SGMO Sifter platform are near 20000 fold effective vs AAV9 but 100s fold more liver DEtargeting"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1946192930303012954) 2025-07-18 12:58:47 UTC 4000 followers, XXX engagements "$XBI Chart of the Week: Nektar looking long in the tooth $NKTR is now in its 35th year of drug development without marketing its own product joining the likes of $SGMO + $CYTK in longest product development cycles. a chance to beat $IMGN ImmunoGen's 40-plus year record"  [@BiotechAnalysst](/creator/x/BiotechAnalysst) on [X](/post/tweet/1938489157460103586) 2025-06-27 06:46:45 UTC 4002 followers, 5349 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiotechAnalysst Phoenix Biotech XXX
Phoenix Biotech XXX posts on X about $sgmo, $4503t, $xbi, pfe the most. They currently have XXXXX followers and 1075 posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX +51%
Mentions: XX #
- X Months XXX -XX%
- X Year XXX +59%
Followers: XXXXX #
- X Week XXXXX +0.23%
- X Month XXXXX +0.83%
- X Months XXXXX +7.50%
- X Year XXXXX +28%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks
Social topic influence $sgmo #1, $4503t #1, $xbi, pfe, $pfe, aav, abbv, $cogt, $repl, $akro
Top assets mentioned Bitcoin Incognito (XBI) Pfizer, Inc. (PFE) Akropolis (AKRO) Biogen Inc (BIIB) Merck & Co., Inc. (MRK) Bristol-Myers Squibb Co (BMY) AbbVie Inc (ABBV) TG Therapeutics, Inc. (TGTX) Insmed, Inc. (INSM) Axsome Therapeutics, Inc (AXSM) ADMA Biologics, Inc. (ADMA) ExlService Holdings, Inc. (EXLS) SpringWorks Therapeutics, Inc. Common Stock (SWTX) BridgeBio Pharma, Inc. Common Stock (BBIO) Krystal Biotech, Inc. Common Stock (KRYS) Blueprint Medicines Corporation (BPMC) Revolution Medicines, Inc. Common Stock (RVMD) Summit Therapeutics Inc. Common Stock (SMMT) Scholar Rock Holding Corporation Common Stock (SRRK) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Merus N.V. Common Shares (MRUS) Edgewise Therapeutics, Inc. Common Stock (EWTX) CRISPR Therapeutics AG (CRSP) Sarepta Therapeutics, Inc. (SRPT) Cytokinetics Inc. (CYTK) Immunogen Inc (IMGN)
Top Social Posts #
Top posts by engagements in the last XX hours
"more hiring @ $SGMO X more jobs posted tonight"
@BiotechAnalysst on X 2025-07-18 14:51:28 UTC 4000 followers, 3812 engagements
"$SGMO and Astellas: rAAV Gene Therapies for RARE NEURO Diseases re "Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases" #STAC_BBB" @BiotechAnalysst on X 2025-07-10 16:04:25 UTC 4000 followers, 4276 engagements
"#Astellas say #gene #editing might be next . $SGMO Astellas is doubling down on gene therapy Building an end-to-end AAV platform from research to commercial Strategic partnerships driving CNS and rare disease programs" @BiotechAnalysst on X 2025-07-17 14:08:03 UTC 4000 followers, 3197 engagements
"Bernsten $XBI M&A - Who might buy whom largest demand: $MRK $PFE $BMY $ABBV and $BIIB targets: $TGTX $INSM $AXSM $ADMA $EXLS $ASND $SWTX $BBIO $KRYS $BPMC $RVMD $SMMT $SRRK $QURE $RYTM $AKRO $MRUS $EWTX $REPL $COGT" @BiotechAnalysst on X 2025-03-11 08:40:23 UTC 4000 followers, 21.7K engagements
"$XBI Biggest Biotech Outflows in Years ($1.546B of net outflows last week) but $CRSP insider buys for 50milli (or half a $SGMO marketcap)" @BiotechAnalysst on X 2025-07-18 13:35:47 UTC 4000 followers, 2335 engagements
"#Astellas says "We see #more platform #development together with (them) Sangamo $SGMO to actually create the next generation of gene therapy .#neuromuscular disease strategy" @BiotechAnalysst on X 2025-07-10 16:18:02 UTC 4000 followers, 5883 engagements
"$sgmo Said has dmd cure ready in fridge Roche should dump $srpt and go all in $sgmo. As for sangamo it was always patients first" @BiotechAnalysst on X 2025-07-19 19:04:02 UTC 4000 followers, 2429 engagements
"#Astallas says: "We look at predominantly #Gene #replacement ." re $SGMO #MINT" @BiotechAnalysst on X 2025-07-17 14:12:23 UTC 4000 followers, 3111 engagements
"$PROK minus VS $SGMO plus eGFR Kidney slope" @BiotechAnalysst on X 2025-07-09 10:58:34 UTC 4000 followers, 6621 engagements
"@GeneInvesting @ShortsellerST yes thats X of many new ones AAV9 had often problems ie $PFE DMD death too $SGMO uses rAAV2/6 for fabry w/o problems the next gen delivery capsids from $SGMO Sifter platform are near 20000 fold effective vs AAV9 but 100s fold more liver DEtargeting" @BiotechAnalysst on X 2025-07-18 12:58:47 UTC 4000 followers, XXX engagements
"$XBI Chart of the Week: Nektar looking long in the tooth $NKTR is now in its 35th year of drug development without marketing its own product joining the likes of $SGMO + $CYTK in longest product development cycles. a chance to beat $IMGN ImmunoGen's 40-plus year record" @BiotechAnalysst on X 2025-06-27 06:46:45 UTC 4002 followers, 5349 engagements